A subcutaneous arteriovenous graft system includes an arteriovenous graft having an arterial end, a venous end opposite to the arterial end and an internal volume between the arterial end and the venous end, and a valve device that can be arranged in an open state, in which fluid flow through the graft is possible and a closed state in which the fluid flow through the arteriovenous graft is blocked. The valve device is constructed to decrease, in the closed state of the valve device, the internal volume of the complete graft to substantially zero.

A catheter insertable into a urethra to drain urine from a bladder includes a tubular portion, a sleeve disposed relative to the tubular portion, with the tubular portion having a bendable zone that is configured to allow the catheter to fold to a compact length. The catheter has a total catheter length measured between an end of a connector that is attachable to a drainage bag and an insertion end of the tubular portion that is insertable into the bladder. The compact length is less than the total catheter length, and the sleeve is operable to support the tubular portion by removing the bend in the bendable zone to thus align the connector axially with the insertion end of the tubular portion.

A compliance restoration device includes a compliance balloon lumen, a chamber support structure disposed in the compliance balloon lumen and configured to expand to support an expanded volume of the compliance balloon lumen, and a spring assembly configured to cause the chamber support structure to expand by applying a force on a first end of the chamber support structure.

The present invention relates to a multi-reservoir port, catheter, and non-coring needle system that supports high-flow applications such as hemodialysis and apheresis. In particular, the invention relates to improvements to provide optimal flow rates, septum life, and septum/needle stability when introducing fluid into the multi-reservoir port.

Provided is a treatment method and a medical device that can intentionally and locally administer a drug to a lesion area appearing in a narrow blood vessel such as a retinal blood vessel and a spinal blood vessel. The treatment method has an introduction step of introducing a medical elongated body having a drug holder for holding a drug into a living body, an arrangement step of arranging the drug holder at a treatment target inside the living body, and a discharge step of discharging the drug to the treatment target by releasing the drug held by the drug holder.

A diagnostic transceiver assembly includes a diagnostic unit that may be implanted into a human body. The diagnostic unit monitors physiological functions of the human body to include heart rate and blood serum levels. The diagnostic unit generates a diagnostic sequence when the diagnostic unit detects blood serum levels outside of a trigger ratio. A dispensing unit may be implanted into the human body. The dispensing unit is in fluid communication with the human circulatory system. The dispensing unit contains insulin. The dispensing unit releases a measured amount of the insulin into the human circulatory system in response to the diagnostic sequence.

A system is provided which includes at least one first sensor subsystem configured to be worn on or implanted within a recipient's head and to generate first signals indicative of motion of the head and vibrational noise experienced by the recipient. The system further includes at least one second sensor subsystem spaced from the at least one first sensor subsystem. The second sensor subsystem is configured to generate second signals at least partially indicative of the vibrational noise experienced by the recipient. The system further includes signal processing circuitry configured to receive the first signals and the second signals, to filter the first signals in response at least in part to the second signals, and to generate third signals indicative of the motion of the head.

In a pump housing having an interior for accommodating a pump rotor, which may be transferred from a radially compressed state into a radially expanded state, and comprises a housing skin revolving in circumferential direction, as well as at least one reinforcement element, a stretch-resistant element revolving in circumferential direction is provided, which is stretched less than 5% in the expanded state as opposed to the force-free state in circumferential direction, and which limits any further expansion of the pump housing in radial direction.

A by-pass shunt for use with a bodily fluid pump. The by-pass shunt includes an inflow conduit, an outflow conduit, and an intermediate conduit fluidically coupling the inflow and outflow conduits. A flow restrictor is operably coupled to a portion of the intermediate conduit and is configured to reduce a fluid flow from the outflow conduit, through the intermediate conduit, and into the inflow conduit.

A cerebral spinal fluid shunt plug includes a shunt plug housing having a shunt valve recess formed therein and a window recess with an access hole. The cerebral spinal fluid shunt plug also includes a shunt valve shaped and dimensioned for positioning within the shunt valve recess of the shunt plug housing and a lucent disk shaped and dimensioned for the passage through the central access hole of the shunt plug housing. In another embodiment, a cerebral spinal fluid shunt plug includes a shunt plug housing having a shunt valve recess formed therein and an intracranial monitoring device recess with an access hole. A shunt valve is positioned within the shunt valve recess of the shunt plug housing and an intracranial monitoring device is passed through the central access hole of the shunt plug housing.